Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $140.4 million.

  • Bio-Techne's Total Current Liabilities fell 1291.73% to $140.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $140.4 million, marking a year-over-year decrease of 1291.73%. This contributed to the annual value of $175.8 million for FY2025, which is 1033.39% up from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Total Current Liabilities is $140.4 million, which was down 1291.73% from $144.5 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's Total Current Liabilities peaked at $176.0 million during Q2 2022, and registered a low of $127.8 million during Q3 2023.
  • For the 5-year period, Bio-Techne's Total Current Liabilities averaged around $148.1 million, with its median value being $143.3 million (2024).
  • Per our database at Business Quant, Bio-Techne's Total Current Liabilities skyrocketed by 4276.45% in 2021 and then plummeted by 2699.1% in 2023.
  • Bio-Techne's Total Current Liabilities (Quarter) stood at $154.8 million in 2021, then fell by 17.06% to $128.4 million in 2022, then rose by 5.32% to $135.2 million in 2023, then grew by 19.24% to $161.3 million in 2024, then fell by 12.92% to $140.4 million in 2025.
  • Its last three reported values are $140.4 million in Q4 2025, $144.5 million for Q3 2025, and $175.8 million during Q2 2025.